Patents by Inventor Shiqi HU

Shiqi HU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240148944
    Abstract: The present disclosure provides compositions and methods relating to the use of stents treated with therapeutic biologics for the treatment of cardiovascular diseases and conditions. In particular, the present disclosure provides novel compositions and methods for conjugating therapeutic extracellular vesicles to a stent to not only regulate vascular remodeling and inflammation, but also promote the regeneration of the injured tissue.
    Type: Application
    Filed: March 10, 2022
    Publication date: May 9, 2024
    Inventors: Ke Cheng, Shiqi Hu
  • Publication number: 20230241121
    Abstract: The present disclosure provides compositions and methods relating to the use of exosomes derived from human dermal papilla (DP) cells. In particular, the present disclosure provides novel compositions and methods for generating and maintaining exosomes derived from DP spheroids, as well as compositions and methods for delivering exosomes to a subject for various therapeutic purposes, such as the treatment of diseases and conditions related to hair follicle development.
    Type: Application
    Filed: March 30, 2021
    Publication date: August 3, 2023
    Inventors: Ke Cheng, Shiqi Hu
  • Patent number: 11331387
    Abstract: Disclosed are a self-assembled drug-loading system containing a hydrophilic phototherapeutic drug and a hydrophobic chemotherapeutic drug, a preparation method therefor and the use thereof for preparing an anti-tumor drug. The self-assembled drug-loading system is a water-soluble complex or water-dispersible nanoparticles formed by means of ?-? interaction or hydrophobic interaction between the phototherapeutic drug and the chemotherapeutic drug, wherein the molar ratio of the phototherapeutic drug to the chemotherapeutic drug is 2:1 to 1:10.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: May 17, 2022
    Assignee: SHANGHAI BEST-LINK BIOSCIENCE
    Inventors: Youqing Shen, Shiqi Hu
  • Publication number: 20210186831
    Abstract: The present disclosure provides compositions and methods relating to the use of exosomes derived from human dermal fibroblasts (HDFs). In particular, the present disclosure provides novel compositions and methods for generating and maintaining exosomes derived from HDF spheroids, as well as compositions and methods for delivering the exosomes to a subject for various therapeutic purposes, such as the treatment of skin conditions.
    Type: Application
    Filed: December 18, 2020
    Publication date: June 24, 2021
    Inventors: Ke Cheng, Shiqi Hu
  • Publication number: 20190336604
    Abstract: Disclosed are a self-assembled drug-loading system containing a hydrophilic phototherapeutic drug and a hydrophobic chemotherapeutic drug, a preparation method therefor and the use thereof for preparing an anti-tumor drug. The self-assembled drug-loading system is a water-soluble complex or water-dispersible nanoparticles formed by means of ?-? interaction or hydrophobic interaction between the phototherapeutic drug and the chemotherapeutic drug, wherein the molar ratio of the phototherapeutic drug to the chemotherapeutic drug is 2:1 to 1:10.
    Type: Application
    Filed: December 14, 2017
    Publication date: November 7, 2019
    Inventors: Youqing SHEN, Shiqi HU